1 Thompson CS, Hakim AM. Living beyond our

physiological means:small vessel disease of the brain

is an expression of a systemic failure in arteriolar

function:a unifying hypothesis[J]. Stroke, 2009,

40:e322-e330.

2 Wardlaw JM, Smith C, Dichgans M. Mechanisms of

sporadic cerebral small vessel disease:insights from

neuroimaging[J]. Lancet Neurol, 2013, 12:483-497.

3 Pantoni L. Cerebral small vessel disease:f rom

pa t hogene si s a nd cl i n ic a l cha r a c t e r i s t ic s to

therapeutic challenges[J]. Lancet Neurol, 2010, 9:689-

701.

4 Knot t ne r us IL, Ten Cat e H, Lodde r J, e t a l.

Endothelial dysfunction in lacunar stroke:a systematic

review[J]. Cerebrovasc Dis, 2009, 27:519-526.

5 Giwa MO, Wi l l i ams J , Eld e r f i e ld K, e t a l .

Neuropathologic evidence of endothelial changes in

cerebral small vessel disease[J]. Neurology, 2012,

78:167-174.

6 Hainsworth AH, Markus HS. Do in vivo experimental

models reflect human cerebral small vessel disease?

A systematic review[J]. J Cereb Blood Flow Metab,

2008, 28:1877-1891.

7 Schreiber S, Bueche CZ, Garz C, et al. Blood brain

barrier breakdown as the starting point of cerebral

small vessel disease?-New insights f rom a rat

model[J]. Exp Transl Stroke Med, 2013, 5:4.

8 Ba i l e y EL, Wa r d l aw JM, Gr a h am D, e t a l .

Ce r ebr a l sma l l ve s sel endothel ia l st r uct u r a l

changes predate hyper tension in st roke-prone

spontaneously hypertensive rats:a blinded, controlled

immunohistochemical study of 5- to 21-week-old

rats[J]. Neuropathol Appl Neurobiol, 2011, 37:711-726.

9 Topakian R, Barrick TR, Howe FA, et al. Blood-brain

barrier permeability is increased in normal-appearing

white matter in patients with lacunar stroke and

leucoaraiosis[J]. J Neurol Neurosurg Psychiatry, 2010,

81:192-197.

10 Wardlaw JM, Doubal FN, Valdes-Hernandez M, et

al. Blood-brain barrier permeability and long-term

clinical and imaging outcomes in cerebral small vessel

disease[J]. Stroke, 2013, 44:525-527.

11 Ogata J, Yamanishi H, Ishibashi-Ueda H. Cerebral

small vessel disease:the pathological features of

cerebral amyloid angiopathy[J]. Brain Nerve, 2013,65:879-885.

12 Haglund M, Passant U, Sjöbeck M, et al. Cerebral

amyloid angiopathy and cortical microinfarcts as

putative substrates of vascular dementia[J]. Int J

Geriatr Psychiatry, 2006, 21:681-687.

13 Schreiber S. Interplay between age, cerebral small

vessel disease, parenchymal amyloid-beta, and Tau

pathology:longitudinal studies in hypertensive strokeprone

rats[EB/OL]. (2014-05-13)[2014-06-30].http://

iospress.metapress.com/content/ch2g7h1517785jk5/?g

enre=article&id=doi%3a10.3233%2fJAD-132618.

14 Onodera O. What is cerebral small vessel disease?[J].

Rinsho Shinkeigaku, 2011, 51:399-405.

15 Thal DR, Capetillo-Zarate E, Larionov S, et al.

Capillary cerebral amyloid angiopathy is associated

with vessel occlusion and cerebral blood f low

disturbances[J]. Neurobiol Aging, 2009, 30:1936-1948.

16 Jiang Q, Zhang ZG, Chopp M. MRI evaluation of

white matter recovery after brain injury[J]. Stroke,

2010, 41:S112-S113.

17 Arai K, Lo EH. An oligovascular niche:cerebral

e nd ot he l i a l c e l l s p r omot e t he s u r v iva l a nd

proliferation of oligodendrocyte precursor cells[J]. J

Neurosci, 2009, 29:4351-4355.

18 Pham LD, Hayakawa K, Seo JH, et al. Crosstalk

between oligodendrocytes and cerebral endothelium

contributes to vascular remodeling after white matter

injury[J]. Glia, 2012, 60:875-881.

19 Jalal FY, Yang Y, Thompson J, et al. Myelin loss

associated with neuroinflammation in hypertensive

rats[J]. Stroke, 2012, 43:1115-1122.

20 S e o JH, Mi y amo t o N, Ha y a k awa K, e t a l .

Oligodendrocyte precursors induce early blood-brain

barrier opening after white matter injury[J]. J Clin

Invest, 2013, 123:782-786.

21 唐杰, 付建辉. 脑小血管病的发病机制[J]. 国际脑血管

病杂志, 2013, 21:293-298.

22 Wiseman S, Marlborough F, Doubal F, et al. Blood

markers of coagulation, fibrinolysis, endothelial

dysfunction and inflammation in lacunar stroke versus

non-lacunar stroke and non-stroke:systematic review

and meta-analysis[J]. Cerebrovasc Dis, 2014, 37:64-75.

23 Ne z u T, Ho s omi N, Ao k i S, e t a l . Al p h a 2 -

macroglobulin as a promising biomarker for cerebral

small vessel disease in acute ischemic st roke

patients[J]. J Neurol, 2013, 260:2642-2649.

24 李伟, 李桂林, 王拥军, 等. 脑小血管病[J]. 中华内科杂

志, 2010, 49:163-164.

25 Jellinger KA. Pathology and pathogenesis of vascular

cognitive impairment-a critical update[J]. Front Aging

Neurosci, 2013, 5:17.

26 Pavlovic AM. Baseline predictors of cognitive decline

in patients with cerebral small vessel disease[EB/OL].

(2014-06-02)[2014-06-30]. http://iospress.metapress.

com/content/t0g313t7t43n1360/?genre=article&id=doi

%3a10.3233%2fJAD-132606.

27 Huijts M, Duits A, Staals J, et al. Basal ganglia

enlarged perivascular spaces are linked to cognitive

function in patients with cerebral small vessel

disease[J]. Curr Neurovasc Res, 2014, 11:136-141.

28 Loitfelder M, Seiler S, Schwingenschuh P, et al.

Cerebral microbleeds:a review[J]. Panminerva Med,

2012, 54:149-160.

29 Chan SL, Sweet JG, Cipolla MJ. Treatment for

cerebral small vessel disease:effect of relaxin on

the function and structure of cerebral parenchymal

arterioles during hypertension[J]. FASEB J, 2013,

27:3917-3927.

30 Bueche CZ, Garz C, Kropf S, et al. NAC changes

the course of cerebral small vessel disease in SHRSP

and reveals new insights for the meaning of stases - a

randomized controlled study[J]. Exp Transl Stroke

Med, 2013, 5:5.

31 Bueche CZ. Impact of N-Acetylcysteine on cerebral

amyloid-bet a plaque s and k id ney damage i n

spontaneously hypertensive stroke-prone rats[EB/OL].

(2014-06-02)[2014-06-30].http://iospress.metapress.

com/content/4717231023w27887/?genre=article&id=d

oi%3a10.3233%2fJAD-132615.

32 Cavalieri M, Schmidt R, Chen C, et al. B vitamins

and magnetic resonance imaging-detected ischemic

brain lesions in patients with recent t ransient

ischemic attack or stroke:the VITAmins TO Prevent

Stroke (VITATOPS) MRI-substudy[J]. Stroke, 2012,

43:3266-3270.

33 Toth P, Tarantini S, Tucsek Z, et al. Resveratrol

treatment rescues neurovascular coupling in aged

mice:role of improved ce rebromic rova scula r

endothelial function and downregulation of NADPH

oxidase[J]. Am J Physiol Heart Circ Physiol, 2014,

306:H299-H308.

34 Ihara M. Management of cerebral small vessel disease

for the diagnosis and treatment of dementia[J]. Brain

Nerve, 2013, 65:801-809.